Renfei Wang

567 total citations
25 papers, 423 citations indexed

About

Renfei Wang is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Renfei Wang has authored 25 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Surgery and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Renfei Wang's work include Thyroid Cancer Diagnosis and Treatment (14 papers), Thyroid and Parathyroid Surgery (5 papers) and Thyroid Disorders and Treatments (5 papers). Renfei Wang is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (14 papers), Thyroid and Parathyroid Surgery (5 papers) and Thyroid Disorders and Treatments (5 papers). Renfei Wang collaborates with scholars based in China, United States and United Kingdom. Renfei Wang's co-authors include Liang Ren, Yu Zhou, Yuwei Wang, Guoqiang Qu, L Liu, Jian Tan, Zhaowei Meng, Guizhi Zhang, Weidong Le and Zhi‐Li Huang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Neuropharmacology.

In The Last Decade

Renfei Wang

23 papers receiving 414 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Renfei Wang China 10 137 85 81 55 52 25 423
Ying Hu China 13 97 0.7× 51 0.6× 23 0.3× 30 0.5× 34 0.7× 79 568
Baharudin Abdullah Malaysia 15 60 0.4× 55 0.6× 89 1.1× 40 0.7× 382 7.3× 128 1.0k
Leandro Borges Brazil 12 186 1.4× 23 0.3× 73 0.9× 36 0.7× 21 0.4× 31 545
Huiyu Liu China 14 46 0.3× 19 0.2× 65 0.8× 30 0.5× 97 1.9× 44 636
Ji Eun Kim South Korea 13 36 0.3× 17 0.2× 30 0.4× 82 1.5× 51 1.0× 41 419
Tongyu Wang China 13 43 0.3× 39 0.5× 35 0.4× 53 1.0× 240 4.6× 51 695
Venugopalan Y. Vishnu India 14 51 0.4× 18 0.2× 146 1.8× 22 0.4× 50 1.0× 133 610
Seok Lim Australia 7 57 0.4× 20 0.2× 94 1.2× 52 0.9× 8 0.2× 15 326

Countries citing papers authored by Renfei Wang

Since Specialization
Citations

This map shows the geographic impact of Renfei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renfei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renfei Wang more than expected).

Fields of papers citing papers by Renfei Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renfei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renfei Wang. The network helps show where Renfei Wang may publish in the future.

Co-authorship network of co-authors of Renfei Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Renfei Wang. A scholar is included among the top collaborators of Renfei Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renfei Wang. Renfei Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Yansong, Renfei Wang, Rui Huang, et al.. (2025). Chinese management guidelines for radioactive iodine-refractory differentiated thyroid cancer (2025 edition). European Journal of Nuclear Medicine and Molecular Imaging. 52(10). 3859–3876. 2 indexed citations
3.
Wang, Renfei, et al.. (2024). Modeling and analysis of COVID-19 spreading based on complex network theory. Europhysics Letters (EPL). 148(1). 11001–11001. 1 indexed citations
4.
Wang, Congcong, Yutian Li, Guoqiang Wang, et al.. (2024). Prognostic value of pre-ablation stimulated thyroglobulin in children and adolescents with differentiated thyroid cancer. Future Oncology. 20(40). 3463–3470. 1 indexed citations
5.
Wang, Renfei, Yilin Li, Yong Zou, et al.. (2024). Impact of agent-based intervention strategies on the COVID-19 pandemic in large-scale dynamic contact networks. Physica A Statistical Mechanics and its Applications. 646. 129852–129852.
6.
Yu, Feng, Xue Li, Yanhui Ji, et al.. (2021). Delayed Initial Radioiodine Adjuvant Therapy Does Affect Biochemical Response in Intermediate- to High-Risk Differentiated Thyroid Cancer. Frontiers in Endocrinology. 12. 743310–743310. 10 indexed citations
7.
Zheng, Xiangqian, Xianghui He, Chao Huang, et al.. (2020). Prognostic Value and Dynamics of Antithyroglobulin Antibodies for Differentiated Thyroid Carcinoma. Biomarkers in Medicine. 14(18). 1683–1692. 14 indexed citations
8.
Chen, Li, Ping Cai, Renfei Wang, et al.. (2020). Glutamatergic lateral hypothalamus promotes defensive behaviors. Neuropharmacology. 178. 108239–108239. 14 indexed citations
9.
Yu, Feng, Ruiguo Zhang, Guizhi Zhang, et al.. (2020). Predictive Value of a Thyroid-Absorbed Dose with a Shorter Effective Half-Life on Efficacy in Graves Disease Patients Receiving Iodine-131 Therapy. Medical Science Monitor. 27. e928796–e928796. 3 indexed citations
10.
Wang, Renfei, Guoqiang Qu, Yuwei Wang, et al.. (2020). Gross examination report of a COVID-19 death autopsy.. SHILAP Revista de lepidopterología. 36(1). 21–23. 183 indexed citations
11.
Zhang, Ruiguo, Yueqian Zhang, Jian Tan, et al.. (2019). Antitumor Effect of 131I-Labeled Anti-VEGFR2 Targeted Mesoporous Silica Nanoparticles in Anaplastic Thyroid Cancer. Nanoscale Research Letters. 14(1). 96–96. 24 indexed citations
12.
Zheng, Wei, et al.. (2019). Clinical features and therapeutic outcomes of patients with papillary thyroid microcarcinomas and larger tumors. Nuclear Medicine Communications. 40(5). 477–483. 12 indexed citations
13.
Feng, Siyuan, Wei Zheng, Ruiguo Zhang, et al.. (2018). Clinical characteristics and 131I efficacy of papillary thyroid microcarcinoma and papillary thyroid non-micro carcinoma. 42(2). 111–114. 1 indexed citations
14.
Liu, Na, Qiang Jia, Jian Tan, et al.. (2016). Multiple-factor analysis of the first radioactive iodine therapy in post-operative patients with differentiated thyroid cancer for achieving a disease-free status. Scientific Reports. 6(1). 34915–34915. 21 indexed citations
15.
Wang, Renfei, Jian Tan, & Guizhi Zhang. (2015). Analysis of 2 125 patients with hyperthyroidism after 131I therapy: a retrospective study. Zhonghua neifenmi daixie zazhi. 31(5). 421–426. 1 indexed citations
17.
Jia, Qiang, Zhaowei Meng, Jian Tan, et al.. (2015). Retrospective imaging study on the diagnosis of pathological false positive iodine-131 scans in patients with thyroid cancer. Experimental and Therapeutic Medicine. 10(5). 1995–2001. 9 indexed citations
18.
Wang, Renfei, Jian Tan, Guizhi Zhang, Zhaowei Meng, & Wei Zheng. (2010). A comparative study of influential factors correlating with early and late hypothyroidism after (131)I therapy for Graves' disease.. PubMed. 123(12). 1528–32. 6 indexed citations
19.
Smith, Derek, et al.. (2004). Epidemiology of hand dermatitis among rural nursing students in mainland China: results from a preliminary study. Rural and Remote Health. 5 indexed citations
20.
Wang, Renfei, et al.. (1992). [A survey of the relationships between children and their parents in chronic disease risk factors, health knowledge and lifestyles].. PubMed. 8(12). 679–91. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026